Genetically Modified Mesenchymal Stromal Cells in Cartilage Regeneration

Area of Science:

• Regenerative Medicine
• Biotechnology
• Orthopedics

Background:

• Articular cartilage injuries are prevalent, often leading to osteoarthritis and trauma.
• Current treatments lack complete cartilage regeneration capabilities.
• Mesenchymal stromal cells (MSCs) show promise but face challenges like hypertrophic differentiation and reduced chondrogenesis in inflammatory conditions.

Purpose of the Study:

• To review genetic engineering strategies for enhancing MSC-based cartilage regeneration.
• To discuss MSC biofunctions and the efficacy/safety of genetic modification.
• To outline challenges and prospects for clinical translation of modified MSCs.

Main Methods:

• Literature review of genetic engineering techniques for MSCs.
• Analysis of viral and nonviral gene delivery methods.
• Evaluation of MSC biofunctions and therapeutic outcomes.

Main Results:

• Genetic modification can optimize MSCs for improved chondrogenesis and reduced hypertrophic differentiation.
• Various viral and nonviral strategies demonstrate potential for enhancing MSC efficacy.
• Understanding MSC biofunctions is crucial for successful genetic engineering.

Conclusions:

• Genetically modified MSCs offer a promising avenue for effective cartilage regeneration.
• Addressing challenges in delivery, efficacy, and safety is key for clinical translation.
• Further research is needed to fully realize the potential of engineered MSCs in treating cartilage defects.